Tuesday, August 4, 2026 is one for the books. The S&P 500 topped its June closing record for the first time — the fourth straight session of gains. The Dow Jones reached another all-time high. The Nasdaq surged 671 points on the back of AI demand confirmation and easing Iran war fears. And beneath the index-level celebration, a handful of individual stocks are posting some of the most explosive moves of the year. From a small medical device company with a cancer patent that shocked the market to an AI GPU infrastructure play nobody saw coming, here are the 10 top stock gainers of August 4, 2026 — with the full story behind every move.
The Market Backdrop: Why Everything Is Rallying
The macro catalyst is clean and powerful:
- WTI crude oil dropped 5% (approximately $5.20/barrel) after President Trump announced over the weekend he has decided to hold off on new strikes against Iran — easing the geopolitical risk premium that had kept oil and fear elevated
- Palantir’s Q2 2026 beat (released August 3 after close) reassured investors that AI enterprise demand is accelerating — not plateauing
- Earnings season continuing to deliver: AMRC, AEIS, IBTA, and BLZE all beat estimates materially this session
- AMD and SpaceX (SPCX) report after the close today — setting up the next potential market catalyst
With oil lower and AI stronger, the market is in a clear risk-on posture — and it’s showing.
#1 — AMIX (Autonomix Medical Inc.) | +386% — The Day’s Most Explosive Move
Price: ~$17.76 (Benzinga) | Volume: 110 million shares (34x average)
When a small-cap medical device company surges nearly 400% in a single session, the catalyst has to be extraordinary. Tuesday’s AMIX move is the definition of extraordinary.
The Catalyst: U.S. Patent No. 12,433,670
Autonomix Medical announced the issuance of U.S. Patent No. 12,433,670, titled “Systems and Methods for Treating Cancer and/or Augmenting Organ Function.” This patent is not a routine IP filing — it is the broadest cancer-targeting patent in the company’s history.
What the patent covers:
- Minimally invasive catheter systems that sense, map, and selectively target nerves associated with tumors
- Records electrophysiological neural signals and delivers energy or therapeutic agents directly to cancer-related nerves
- Therapeutic applications across pancreatic, prostate, breast, colorectal, liver, ovarian, and bone cancers
- Additional applications for pain modulation, organ function enhancement, and autonomic nervous system disorders
CEO Brad Hauser: “This patent represents another meaningful expansion of our intellectual property portfolio and further demonstrates the breadth of our proprietary technology platform.”
Key Data Points:
| Metric | Data |
|---|---|
| Price (Aug 4, 2026) | ~$17.76 (Benzinga real-time) |
| Price change | +386.58% in a single session |
| Volume | 110 million shares (34x average daily volume) |
| Patent issued | U.S. No. 12,433,670 |
| Cancer types covered | Pancreatic, prostate, breast, colorectal, liver, ovarian, bone |
| Total IP portfolio | 112 issued or pending patents globally |
| Prior price (Aug 3) | ~$3.65 |
| Nasdaq compliance | Regained June 24, 2026 (after reverse split June 23) |
The bigger AMIX story: Tuesday’s patent is the third major IP filing in three weeks — adding to prior grants for overactive bladder diagnosis and a Canadian patent for neural sensing. The rapid IP acceleration suggests the company is advancing toward clinical trial readiness, with a potential U.S. pivotal trial as the next major catalyst. The overactive bladder market alone affects approximately 37 million Americans.
#2 — MOVE (Corvex Inc.) | +53% to $16.46 — The Nvidia Blackwell AI Infrastructure Bet
Price: $16.46 | Gain: +53% (Benzinga) / +74.4% at session peak
Corvex, Inc. — an AI infrastructure company based in Arlington, Virginia — signed a deal Tuesday morning that sent its stock into the stratosphere.
The Deal: NVIDIA Blackwell GPU Clusters for a Mystery AI Company
- Multi-year agreement to provide clusters of NVIDIA Blackwell HGX B200 GPUs connected with NVIDIA Quantum-2 InfiniBand networking to “a leading AI company” (client not disclosed)
- Deployment includes dedicated high-speed storage and CPUs for large-scale AI workloads
- Corvex installed and commissioned the liquid-cooled Nvidia HGX B200 capacity in approximately two weeks after equipment arrival
- First cluster portion delivered in Q1 2026; remaining capacity delivered in Q2 and Q3 2026
- Full run-rate revenue begins mid-Q3 2026 — meaning this deal starts generating real cash this quarter
How Corvex financed it (the headline detail investors loved):
- Funded via debt financing, customer prepayments, and cash on hand
- No additional equity financing — zero dilution to existing shareholders
- CEO: “AI builders shouldn’t have to choose between cutting-edge capability and financial discipline”
| Metric | Data |
|---|---|
| Price (Aug 4) | $16.46 (+53%) |
| Pre-announcement price | ~$10.76 |
| GPU type | NVIDIA Blackwell HGX B200 |
| Networking | NVIDIA Quantum-2 InfiniBand |
| Revenue start | Mid-Q3 2026 (full run-rate) |
| Financing | Debt + customer prepayments (no equity dilution) |
| Market cap | ~$299 million |
MOVE’s deal structure — using customer prepayments to fund infrastructure — is the AI compute equivalent of a project-financed build. It’s capital-efficient, scalable, and immediately revenue-generating. For a micro-cap in the AI compute space, this is exactly the kind of contract institutional investors want to see.
#3 — IBTA (Ibotta Inc.) | +46% to $35.80 — The Earnings Beat That Rewrites the Story
Price: $35.80 | Gain: +46% | Prior close: $24.58
Ibotta had been one of 2026’s quiet underperformers — down 27.4% before earnings, trading at $24.58 against an average analyst price target of $33.43. Then Q2 happened.
Q2 2026 Results vs. Expectations:
| Metric | Actual | Estimate | Beat |
|---|---|---|---|
| Revenue | $88.91 million | $84.95 million | +4.7% |
| Non-GAAP EPS | $0.46 | $0.37 | +24.2% |
| Adjusted EBITDA | $16.54 million | $11.12 million | +48.7% |
| Q3 Revenue Guidance (midpoint) | $88 million | $85.86 million | Above est. |
| Q3 EBITDA Guidance (midpoint) | $13 million | $11.38 million | Above est. |
The 7-Eleven Partnership — The Real Catalyst: Ibotta announced it will be the exclusive third-party provider of CPG digital promotions to the 7-Eleven, 7NOW, and Speedway apps — covering more than 11,500 U.S. store locations. This is a landmark retail exclusive that expands Ibotta’s distribution into the largest convenience store network in the U.S.
The deal is structurally important: Ibotta’s model pays per redemption, and 7-Eleven’s high-traffic convenience format creates a natural high-frequency redemption environment. This is not a one-time promotional deal — it’s an exclusive, ongoing distribution channel.
Needham raised its price target to $45 (from $33) — Buy rating maintained.
#4 — BLZE (Backblaze Inc.) | +37.78% to $21.48 — A $335 Million AI Storage Landgrab
Price: $21.48 | Gain: +37.78%
Backblaze’s Q2 report confirmed what bulls have been arguing all year: this is not just a backup storage company. It is an AI workload storage infrastructure play — and the market is repricing accordingly.
Q2 2026 Results and the CoreWeave Deal:
| Metric | Actual | Estimate | Beat |
|---|---|---|---|
| Total Revenue | $42.7 million | $39.93 million | +6.9% |
| YoY Revenue Growth | +18% | — | Strong |
| B2 Cloud Storage Revenue | $26.6 million | $19.8M (Q2 2025) | +34% YoY |
| B2 Net Revenue Retention Rate | 113% | — | Expanding |
| Adjusted EBITDA Margin (FY26 guide) | 27–29% | 23–25% prior | Upgraded |
| FY2026 Revenue Guidance | $172–$174M | $162.3M | +6.9% above |
| Q3 2026 Revenue Guidance | $44.4–44.8M | $41.2M | +8.2% above |
The CoreWeave deal is the headline number: A $335.1 million multi-year Master Strategic Agreement for B2 Cloud Storage and managed storage services — pushing remaining performance obligations to $396 million. This is not a small pilot. It is a commitment from one of AI’s fastest-growing hyperscalers that Backblaze is their storage layer of choice.
CEO Gleb Budman: “AI workloads require scalable exabyte capacity with performance at attractive economics — Backblaze is built to win.”
#5 — XGN (Exagen Inc.) | +39% — Diagnostics Company Posts Record Quarter
Gain: +39% | Catalyst: Record Q2 revenue + raised full-year guidance toward profitability
Exagen filed its Q2 2026 quarterly report and simultaneously announced record quarterly revenue, raising its full-year outlook and moving notably closer to profitability. The specialty diagnostics company — which focuses on rheumatic and inflammatory disease testing — is benefiting from expanding test adoption and reimbursement stability.
Key details:
- Record Q2 revenue
- Full-year outlook raised
- Trajectory toward profitability — a critical turning point for a development-stage diagnostics company
- Volume driven by growing rheumatology testing adoption
#6 — AMRC (Ameresco Inc.) | +29.4% — Clean Energy’s Record-Setting Quarter
Gain: +29.4% | Q2 EPS $0.20 vs. $0.16 estimate (+25% beat)
Ameresco — one of the market’s leading clean energy and energy efficiency solution providers — delivered a Q2 2026 that investors hadn’t priced in.
The Numbers:
| Metric | Actual | Estimate | Beat |
|---|---|---|---|
| EPS | $0.20 | $0.16 | +25% |
| Revenue | $515.5 million | $460.72 million | +11.9% |
| YoY Revenue Growth | +9% | — | — |
| New Project Awards | $1.8 billion (record) | — | Historic |
| FY2026 EPS Guidance (raised) | $1.15–$1.35 | — | — |
The $1.8 billion in new project awards is the company’s most significant new business milestone ever — driven by U.S. government and municipal energy efficiency contracts. With Q4 historically stronger, management’s forward guidance is cautiously bullish: “We expect Q4 activity to be higher due to normal seasonal cadence.”
#7 — AEIS (Advanced Energy Industries) | +29%+ — Semiconductor Equipment Roars
Gain: +29%+ | Q2 adj EPS $2.74 vs. $2.20 estimate (+24.5% beat, +31% YoY)
Advanced Energy Industries — a manufacturer of power conversion and control equipment for semiconductor fabrication — delivered one of Q2 earnings season’s cleanest beats.
| Metric | Actual | Estimate | Beat |
|---|---|---|---|
| Adj. EPS | $2.74 | $2.20 | +24.5% |
| Revenue | $574.1 million | $542.8 million | +5.7% |
| YoY Revenue Growth | +30% | — | — |
| Gross Margin | 41.1% | — | — |
| Q3 Revenue Guidance | $620–660M | $573.71M est | +8.1% above |
The Q3 guide of $620–660M significantly above the $573.71M consensus confirms that AI chip manufacturing demand — the primary driver of Advanced Energy’s power conversion equipment — remains structurally elevated.
#8 — PLTR (Palantir Technologies) | Continuing Strong — AI Demand Confirmed
August Month Gain: +26.9% | Session: Positive
Palantir’s Q2 2026 results — released August 3 after the close — directly reassured the entire AI investment complex. Bloomberg noted that the “solid outlook from Palantir reassured investors about artificial-intelligence demand.” Palantir has beaten consensus estimates in each of its last eight consecutive quarters.
Consensus heading in: Revenue $1.81B, EPS $0.34. The Q2 2026 results will be the day’s most referenced earnings report as the market validates the AI monetization thesis.
#9 — MCD (McDonald’s Corporation) | Q2 Earnings Top Views
McDonald’s reported Q2 2026 results that topped analyst expectations — a solid macro read on global consumer spending and quick-service restaurant resilience.
Why it matters today: With WTI crude down 5%, commodity-linked food cost pressures are easing — McDonald’s oil/frying fat costs fall alongside crude. The Q2 beat, combined with today’s energy price decline, creates a margin expansion narrative for Q3.
🔗 McDonald’s investor relations at corporate.mcdonalds.com/investors
#10 — BP (BP Plc) | Q2 Profit Doubles — Oil Giant Defies Falling Crude
Gain: Positive session | Q2 underlying profit: $5.73 billion
BP’s Q2 2026 profit more than doubled year-over-year to $5.73 billion, beating the $5.11 billion consensus. The company attributed the outperformance to higher energy prices (Q2 average crude was above current levels), strong trading, and improved refining margins.
The dividend signal: BP increased its quarterly dividend by 4% to 8.66 cents per ordinary share — a direct signal of management’s confidence in cash flow durability. Capital expenditure guidance of $13.5–$14 billion for 2026 was maintained.
The Day’s Dominant Theme: AI + Earnings Beat + Iran Relief
Three forces are producing today’s record-setting market:
- Iran peace optimism → Oil -5% → Consumer/manufacturing cost relief → Stocks up
- AI demand confirmed → Palantir beat, Corvex GPU deal, Backblaze CoreWeave → Tech/AI names explode
- Q2 earnings season broadly strong → IBTA, BLZE, AMRC, AEIS, MCD, BP all delivering genuine beats
The S&P 500 at a new record high, the Dow at an all-time high, and the Nasdaq up 671 points — driven by earnings, geopolitics, and AI infrastructure demand all moving in the same direction simultaneously.
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Always complete independent due diligence prior to executing equity trades.
For live market data, visit TruthsandNews.com | Real-time gainers at Public.com Markets | Premarket movers at TheDesperateTrader.com | StockMarketWatch at StockMarketWatch.com
About The Author
